The guests frame their work as talking to peers who understand the same pains, not selling a catalog.

to the University of Oxford on a 4-year Wellcome Trust Scholarship in Neuroscience, through which I gained I work with invertebrate animal models (mainly D. melanogaster) and in vitro techniques to pick apart adhesion GPCRs, and extends to the development of novel screening approaches to identify pharmacological modulators

The main target of Dr. His laboratory uses knock-out and transgenic mouse models, along with different cell culture systems,

steroidogenesis in regulating sexual determination and adrenal and gonadal development using genetic mouse models coupled receptors and receptor activity modifying proteins in vascular biology, the Caron laboratory has gained

Terry Hebert explains why studying GPCRs in HEK293 cells misses critical biology — and how iPSC-derived models cell type, and is now deploying them in iPSC-derived cardiomyocytes and patient-specific stem cell models failure of a biased agonist exposed the cost of oversimplifying that signaling landscape. iPSC-Derived Models biosensors revealing cell-type-dependent outputs 10:54 Building the toolkit — biosensors, iPSC-derived models and his team are working on understanding receptor signaling in specialized cellular environments to gain

of opioid receptors and is currently focusing on the pharmacology of cannabinoids in the context of pain

The main goal of the GPCR Retreat is to provide a venue for students, post-doctoral fellows, and principal University in Australia, one of the pioneers in the medicinal chemistry, computational and mathematical modelling scientists working in the arenas of structure and signaling, neuroscience, cancer, translational and model

steroidogenesis in regulating sexual determination and adrenal and gonadal development using genetic mouse models coupled receptors and receptor activity modifying proteins in vascular biology, the Caron laboratory has gained Slosky characterized a new class of β-arrestin biased allosteric modulators (BAMs) for the neurotensin Critically, these ligands reduce addiction-associated behaviors in animal models without the side effects

In particular, D2R is the main pharmacological target of antipsychotic drugs prescribed for schizophrenia The Beaulieu group is presently investigating how cell surface express proteins can act as allosteric modulators Translational validation is important to validate findings obtained from experimental models research

Trejo’s research program is to gain a thorough and mechanistic understanding of processes that control critical expertise, and rigorous approaches to examine PAR1 function using human cultured cells and mouse models

The GABA-B Heterodimer Was Hiding in Plain Sight Dr. only survives translation if the coupling profile in the relevant human cells matches the cell-line model Marshall's caution is hard-won: many animal-model-validated GPCR drugs have failed in the clinic precisely wave of GPCR drug design 18:47 Which GPCR families pharma is chasing now — and why 21:23 Why animal model So can we now try and encourage the next cohort of people to be the main speakers at conferences?"

Trejo’s research program is to gain a thorough and mechanistic understanding of processes that control critical expertise, and rigorous approaches to examine PAR1 function using human cultured cells and mouse models San Diego Supercomputer Center, and provided consultation for genetic sequence analysis, molecular modeling

He calls the reinvention painful and brutal, and does it anyway.

Attendees will gain a technical understanding of probe design, selectivity, and validated applications masterclasses with leading researchers Structured networking for scientists and biotech professionals Nonprofit model

His main area of research focuses on the structural and pharmacological bases for hormone-mediated activation The structure was first snapshot of the agonist- and G protein-bound GPCR, providing valuable models We have identified several GPCR ligands that allosterically modulate orthosteric ligand binding and target

Terry Kenakin’s unique course, Development of GPCR Ligands as Therapeutic Drugs , and gain essential April 1 - 3, 2025 | 2nd Peptide-Based Therapeutics Summit - USA April 2 - 3, 2025 | New therapeutic modalities larval growth and embryonic development in the multivoltine strain of Bombyx more Profiling Allosteric Modulators GPCRs in Neuroscience Cortical astrocyte activation triggers meningeal nociception and migraine-like pain β-arrestin-1/endothelin axis in human ovarian fibroblasts Methods & Updates in GPCR Research Histamine-modulated

Listeners will gain perspective on how asking broader questions about receptor biology can reshape drug combines bioinformatic analysis of GPCR expression across human cancers with wet-lab validation in animal models studied receptor function in human physiology, receptor molecular pharmacology in cells, and animal models

Clear Platform Assessment: Gain rapid, independent insight into GPCR platform risks and true therapeutic Organizations Elevate Scientific Offerings: Refine and optimize your GPCR assay platforms and in vitro models We made confident progress on a pivotal program and gained clarity on our next strategic focus.

Each session explores mechanistic models, translational challenges, and real-world therapeutic implications These GPCR webinars focus on conceptual frameworks, models, and translational insight that apply across introduce key concepts, the overall level is advanced and assumes familiarity with pharmacological models Topics may include: Receptor efficacy and operational models Allosteric modulators (PAMs and NAMs) Biased They provide exposure to current thinking, advanced modeling approaches, and expert interpretation of

At UCSF, he develops structural models of GPCRs using sparse experimental data - combining restraints His fluency in both bench and computational languages shapes how he builds models and how he interprets Rather than a setback, it became a forced pivot into computation at precisely the moment his modeling Bench experience as a modeling guardrail Knowing what an EC50 means experimentally, or what a Bmax implies Bender credits his time at the bench with preventing the kind of over-interpretation that models built

each transmembrane bundle that appear to function as both structural anchors and negative allosteric modulators analysis of the GABA-B2-bound lipid site further suggested that lipid acts as a negative allosteric modulator allosteric sites within the transmembrane domain as a more targeted alternative: they offer receptor modulation inside each transmembrane bundle 12:55 - What the lipids actually do - structural components, allosteric modulation , and open questions 14:57 - Disease territory: epilepsy, spasticity, pain, addiction, and the limitations

Antonella Di Pizio on building computational models for GPCRs with almost no crystal structures and almost TAARs look more classical than most chemosensory GPCRs — and that matters for modeling. Di Pizio's workflow is deliberately iterative: build the model, predict binding-site residues, send them out for mutagenesis, fold the experimental results back into the model, rebuild. Collaborators are not recipients of finished predictions — they are partners embedded in the modeling

Her team at InterAx models receptor signaling pathways as systems of time-dependent equations, then runs kinetic assays to refine the models and extract ten to fifteen pharmacological parameters from what Model first, pipette second. InterAx treats GPCR pharmacology the way engineers treat aircraft design: build the mathematical model signaling pathways first, then use controlled kinetic assays as the "wind tunnel" that refines the model

GPCR to gain access to the Affiliate Program. Commissions are paid on qualifying sales made through the affiliate's unique links. Commissions are not paid on sales that are canceled. GPCR pays affiliates via a PayPal account, provided to us when a member joins. Paid Search Dr. GPCR maintains a strict policy on paid search activity.

capabilities include custom assay development, deorphanization, biophysical characterization, translational models Screening campaigns Mechanistic pharmacology studies Custom assay solutions Translational & advanced cell models Radioligand binding, affinity determination, kinetic characterization Biased signaling and allosteric modulation View Advanced Pharmacology & Translational Models Advanced pharmacology and translational models for

a human ortholog linked to vascular malformations and blood-brain barrier dysfunction in vertebrate models completing her PhD in Germany and her postdoctoral work at Columbia University, where she worked on ALS models adhesion GPCR research in Drosophila, CRISPR, epitope tagging, and knockout strategies The logic of model ortholog has been associated with vascular malformations and blood-brain barrier dysfunction in vertebrate models That thread, from a behavioral assay in a fly larva to a clinical phenotype in mice, is what gives the model

Tools That Changed GPCR Pharmacology G-protein-coupled receptors were once described through a simple model The model was clean, teachable, and wrong in ways that took decades to prove. SCIENTIFIC THEMES OF THE CONVERSATION The limits of the binary receptor model and what inverse agonism Every receptor his lab has studied was selected because it was the right model for a question that was The divide illustrated something Bouvier has observed repeatedly: mental models, once useful, can become

strategies to express, reconstitute and assay engineered GPCRs using the visual pigment rhodopsin as a model that stemmed from this work, such as the concept of “functional micro-domains” and the “helix movement model Tom’s lab also pioneered the early use of computational homology modeling, molecular dynamics simulations

postdoctoral role at the Polytechnic University of Turin (Italy), where he developed coarse-grained models tenure-track position, his research spans the development of computational methods such as structure-based models

In this conversation, he describes how attaching a moderately active peptide to a receptor-targeted nanobody The working model is that the nanobody anchors the conjugate at the receptor surface, positioning the camelid nanobodies 25:45 The first nanobody-GPCR ligand conjugate and an unexpected 10,000-fold potency gain